![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/00 | |
C07K 16/10 | |||
C07K 16/28 | |||
C07K 16/40 | |||
A61K 47/68 | |||
A61P 31/00 |
(11) | Number of the document | 3142700 |
(13) | Kind of document | T |
(96) | European patent application number | 15793257.5 |
Date of filing the European patent application | 2015-05-15 | |
(97) | Date of publication of the European application | 2017-03-22 |
(45) | Date of publication and mention of the grant of the patent | 2021-03-03 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/030964 |
Date | 2015-05-15 |
(87) | Number | WO 2015/175874 |
Date | 2015-11-19 |
(30) | Number | Date | Country code |
201461994379 P | 2014-05-16 | US |
(72) |
TSUI, Ping, US
BORROK, Martin, US
DALL`ACQUA, William, US
WU, Yanli, US
BEYAZ-KAVUNCU, Nurten, US
|
(73) |
Medimmune, LLC,
One Medimmune Way, Gaithersburg, Maryland 20878,
US
|
(54) | MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES |
MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES |